These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27998217)

  • 21. Key factors impacting the delivery and financing of oncology care in the United States.
    Goldsmith PJ; Paivanas T
    J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607
    [No Abstract]   [Full Text] [Related]  

  • 22. Paying for Cancer Drugs That Prove Their Benefit.
    Frank RG; Emanuel EJ
    JAMA; 2021 Oct; 326(16):1579-1580. PubMed ID: 34633420
    [No Abstract]   [Full Text] [Related]  

  • 23. Peer review: should we modify our process?
    Berquist TH
    AJR Am J Roentgenol; 2014 Mar; 202(3):463-4. PubMed ID: 24555581
    [No Abstract]   [Full Text] [Related]  

  • 24. Perspectives on Cost and Value in Cancer Care.
    Saltz LB
    JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
    [No Abstract]   [Full Text] [Related]  

  • 25. American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.
    American Society of Clinical Oncology
    J Oncol Pract; 2018 Mar; 14(3):187-192. PubMed ID: 29091534
    [No Abstract]   [Full Text] [Related]  

  • 26. Payer management of oncology gets serious.
    Snyder M; Goldberg L; Ryan T
    Am J Manag Care; 2012 Feb; 18(1 Spec No.):SP6-7. PubMed ID: 22468875
    [No Abstract]   [Full Text] [Related]  

  • 27. US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
    Rappaport M
    J Oncol Pract; 2016 May; 12(5):397. PubMed ID: 27170686
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
    Navarro RP; Morrow T; Baran R
    Manag Care Interface; 2002 Jul; 15(7):55-62. PubMed ID: 12143298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.
    Schnipper LE; Smith TJ; Raghavan D; Blayney DW; Ganz PA; Mulvey TM; Wollins DS
    J Clin Oncol; 2012 May; 30(14):1715-24. PubMed ID: 22493340
    [No Abstract]   [Full Text] [Related]  

  • 30. How to create successful alternative payment models in oncology.
    Miller HD
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673
    [No Abstract]   [Full Text] [Related]  

  • 31. Bad peer reviewers.
    Nature; 2001 Sep; 413(6852):93. PubMed ID: 11557930
    [No Abstract]   [Full Text] [Related]  

  • 32. Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment Model.
    Hwang TJ; LaMattina JL
    JAMA Oncol; 2016 Sep; 2(9):1125-6. PubMed ID: 27388928
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

  • 34. Managing oncology products.
    Penna P
    Manag Care Interface; 2005 Jun; 18(6):41-2. PubMed ID: 16018298
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug assistance programs for the cancer patient.
    Mowad LZ; Richter SS
    Cancer Pract; 2000; 8(1):49-50. PubMed ID: 10732540
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer research: does it deliver for the patient?
    Oldham RK
    Cancer Biother; 1994; 9(2):99-102. PubMed ID: 7812366
    [No Abstract]   [Full Text] [Related]  

  • 37. European perspective on the costs and cost-effectiveness of cancer therapies.
    Drummond MF; Mason AR
    J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
    Tefferi A; Kantarjian H; Rajkumar SV; Baker LH; Abkowitz JL; Adamson JW; Advani RH; Allison J; Antman KH; Bast RC; Bennett JM; Benz EJ; Berliner N; Bertino J; Bhatia R; Bhatia S; Bhojwani D; Blanke CD; Bloomfield CD; Bosserman L; Broxmeyer HE; Byrd JC; Cabanillas F; Canellos GP; Chabner BA; Chanan-Khan A; Cheson B; Clarkson B; Cohn SL; Colon-Otero G; Cortes J; Coutre S; Cristofanilli M; Curran WJ; Daley GQ; DeAngelo DJ; Deeg HJ; Einhorn LH; Erba HP; Esteva FJ; Estey E; Fidler IJ; Foran J; Forman S; Freireich E; Fuchs C; George JN; Gertz MA; Giralt S; Golomb H; Greenberg P; Gutterman J; Handin RI; Hellman S; Hoff PM; Hoffman R; Hong WK; Horowitz M; Hortobagyi GN; Hudis C; Issa JP; Johnson BE; Kantoff PW; Kaushansky K; Khayat D; Khuri FR; Kipps TJ; Kripke M; Kyle RA; Larson RA; Lawrence TS; Levine R; Link MP; Lippman SM; Lonial S; Lyman GH; Markman M; Mendelsohn J; Meropol NJ; Messinger Y; Mulvey TM; O'Brien S; Perez-Soler R; Pollock R; Prchal J; Press O; Radich J; Rai K; Rosenberg SA; Rowe JM; Rugo H; Runowicz CD; Sandmaier BM; Saven A; Schafer AI; Schiffer C; Sekeres MA; Silver RT; Siu LL; Steensma DP; Stewart FM; Stock W; Stone R; Storb R; Strong LC; Tallman MS; Thompson M; Ueno NT; Van Etten RA; Vose JM; Wiernik PH; Winer EP; Younes A; Zelenetz AD; LeMaistre CA
    Mayo Clin Proc; 2015 Aug; 90(8):996-1000. PubMed ID: 26211600
    [No Abstract]   [Full Text] [Related]  

  • 39. Pressure also leads to worthless publications.
    de Carvalho LB
    Nature; 2006 Feb; 439(7078):784. PubMed ID: 16482133
    [No Abstract]   [Full Text] [Related]  

  • 40. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.